Search results
Moderna CEO says he'll give away most of his estimated $4.1 billion fortune
Business Insider via Yahoo News· 2 years agoStephane Bancel, CEO of Moderna.Nancy Lane/MediaNews Group/Boston Herald Moderna's CEO said he plans...
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough...
Business Insider via Yahoo News· 1 year agoStéphane Bancel, the CEO of Moderna.Nancy Lane/MediaNews Group/Boston Herald Moderna's cancer...
Moderna's betting big on personalized vaccines to treat cancer. Its CEO lays out his vision for how...
Business Insider via Yahoo News· 1 year agoModerna CEO Stéphane Bancel wants the COVID-19 vaccine developer to bring its mRNA technology to...
Moderna's Bancel defends COVID-19 vaccine price at Sanders hearing
Yahoo Finance via AOL· 1 year agoModerna's CEO Stéphane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP...
Moderna CEO on AI’s potential to cure cancer
Semafor via Yahoo News· 7 months agoThe Scene Moderna CEO Stéphane Bancel points out his company was using AI years before the ChatGPT hype to create new drugs, like its COVID-19 vaccine....
Moderna CEO grilled over plan to raise Covid vaccine price at Senate hearing
NBC Universal via AOL· 1 year agoModerna CEO Stéphane Bancel defended plans to raise the price of the company's Covid vaccine, saying...
Democrats blast Moderna CEO over plans to quadruple price of COVID-19 vaccine
The Hill via Yahoo News· 1 year agoDemocratic senators lashed out at Moderna CEO Stéphane Bancel in a Thursday hearing over his...
Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday
Yahoo Finance· 1 year agoModerna (MRNA) CEO Stéphane Bancel will join a panel in front of the Senate Health, Education, Labor...
Monkeypox lacks same 'urgency' as COVID-19 for Moderna: CEO
Yahoo Finance via AOL· 2 years agoMonkeypox doesn't carry the same urgency for Moderna (MRNA) as COVID, says CEO Stéphane Bancel....
An Insider At Moderna Lowered Their Holding Recently
Simply Wall St. via Yahoo Finance· 8 months agoFrom what we can see, insiders were net sellers in Moderna, Inc.'s (NASDAQ:MRNA ) during the past 12 months. That is, insiders sold the stock in greater...